Cencora distributes pharmaceuticals and other healthcare products to pharmacies, healthcare providers and other customers. It last closed at $350.36 on Nov 17, down 1.88% on the day. COR reports earnings on Wed, Feb 3, 2027. The average 12-month price target from 8 analysts is $391.25 (+11.7% from the last close), with a high of $413.00 and a low of $375.00. Analyst consensus is Strong Buy, based on the latest ratings from 8 firms (8 buy, 0 hold, 0 sell). Over the past 90 days StreetAlpha recorded 2 whale options trades in COR, 0% of them bullish and 100% bearish. In the past 30 days there were 4 dark pool prints totaling $3.2M, the largest $1.1M.
Each firm's latest rating on COR in the past 90 days
Average 12-month target
$391.25
▲ 11.7% upside
Based on 8 analysts who set a price target on COR in the past 90 days. The average target is $391.25, with a high of $413.00 and a low of $375.00, compared with the last close of $350.36.
Low $375.00Avg $391.25High $413.00
Blue marker: last close $350.36
Highest target$413.00
Average target$391.25
Lowest target$375.00
Latest rating changes
Wells FargoTarget raised
Nov 17Buy$395 → $400
JP MorganTarget raised
Nov 10Buy$390 → $413
Leerink PartnersTarget raised
Nov 5Buy$388 → $405
Evercore ISI GroupTarget raised
Nov 5Buy$350 → $380
Morgan StanleyTarget raised
Oct 30Buy$346 → $377
Date
Firm
Action
Rating
Price target
Nov 17
Wells Fargo
Target raised
Buy
$395 → $400
Nov 10
JP Morgan
Target raised
Buy
$390 → $413
Nov 5
Leerink Partners
Target raised
Buy
$388 → $405
Nov 5
Evercore ISI Group
Target raised
Buy
$350 → $380
Oct 30
Morgan Stanley
Target raised
Buy
$346 → $377
Loading…
Technical Analysis
COR · as of the Nov 17 close · updated after every close
Uptrend
The stock is 3% above its 20 day and 6% above its 50 day average. It is 10% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 58). The nearest support is the Pivot S1 at $347.61, and the nearest resistance the Pivot at $352.45.
Short trendBullish
Long trendBullish
MomentumStrong
StretchNormal
VolatilityHigh, 2.5%/day
Key levels
$377.5452 week high+7.8%
$363.95Swing high (Nov 5)+3.9%
$355.19Pivot R1+1.4%
$352.45Pivot+0.6%
$350.36Last close
$347.61Pivot S1−0.8%
$340.8720 day average−2.7%
$333.05Swing low (Nov 6)−4.9%
$328.2150 day average−6.3%
$320.54100 day average−8.5%
$316.64200 day average−9.6%
$244.8252 week low−30.1%
Indicators
RSI (14)
58.16
Middle of its range
Neutral
MACD
7.16
Above its signal line
Bullish
Stochastic
79.0
Middle of its range
Neutral
ADX (14)
32.9
Trending up
Williams %R
-36.1
Oversold below −80, overbought above −20
Neutral
CCI (20)
90.9
Oversold below −100, overbought above 100
Neutral
Rate of change
+2.8%
Change over 10 sessions
Bullish
ATR (14)
$8.77
Typical daily range, 2.5% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Rising
Short trendBullish
Long trendNot enough history
MomentumStrong
StretchNormal
VolatilityNormal, 5.6%/day
Key levels
$377.5452 week high+7.8%
$363.95Swing high (Nov 5)+3.9%
$355.19Pivot R1+1.4%
$352.45Pivot+0.6%
$350.36Last close
$347.61Pivot S1−0.8%
$340.8720 day average−2.7%
$333.05Swing low (Nov 6)−4.9%
$328.2150 day average−6.3%
$320.54100 day average−8.5%
$316.64200 day average−9.6%
$244.8252 week low−30.1%
Indicators
RSI (14)
61.90
Strong, overbought above 70
Neutral
MACD
9.27
Above its signal line
Bullish
Stochastic
76.4
Middle of its range
Neutral
ADX (14)
19.8
No clear trend
Williams %R
-19.7
Oversold below −80, overbought above −20
Overbought
CCI (20)
172.9
Oversold below −100, overbought above 100
Overbought
Rate of change
+8.9%
Change over 10 sessions
Bullish
ATR (14)
$19.71
Typical daily range, 5.6% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200–
What happened before, for COR
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how COR did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow COR usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How COR has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.
From the company's 10-Q filed Aug 5, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether COR is in one of them and how their past COR trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Cencora
Cencora is a pharmaceutical distributor based in Conshohocken, Pennsylvania. It moves prescription drugs and other healthcare products from drug manufacturers to customers, including retail pharmacies, healthcare providers and health insurers. Most of its customers buy from it on credit, and its operations are shaped by detailed rules on how drugs are tracked and shipped through the supply chain.